Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2022) Yunlong Cao et al.   NATURE

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

(2022) Yueh-Ming Loo et al.   Science Translational Medicine

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

(2022) Sho Iketani et al.   NATURE

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

(2022) Kathryn Westendorf et al.   Cell Reports

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

(2022) Jasmin Quandt et al.   Science Immunology

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

(2022) Yunlong Cao et al.   NATURE

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

(2022) Houriiyah Tegally et al.   NATURE MEDICINE

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

(2021) Richard Copin et al.   CELL

CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants

(2021) Chaoran Chen et al.   BIOINFORMATICS

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

(2020) Dora Pinto et al.   NATURE